Establishment and Use of Primary Cultured Astrocytes from Alexander Disease Model Mice
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212100 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yuto Kubota und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropharmacology, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Chuo 409-3898, Japan. Hauptthemen laut MEDLINE: Alexander Disease, Astrocytes, Disease Models, Animal, Glial Fibrillary Acidic Protein. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, University of Yamanashi.
Abstract (Originalsprache)
Alexander disease (AxD) is an intractable neurodegenerative disease caused by mutations in glial fibrillary acidic protein (GFAP), which is predominantly expressed in astrocytes. Thus, AxD is a primary astrocyte disease. However, it remains unclear how GFAP mutations affect astrocytes and cause AxD pathology. Three features are characteristic of AxD astrocytes in vivo: (1) Rosenthal fibers (RFs), the hallmark of AxD; (2) aberrant Ca2+ signals (AxCa); and (3) upregulation of disease-associated genes (AxGen). We established a primary culture system for astrocytes from an AxD transgenic mouse model, and used it to analyze the above features of AxD pathogenesis in astrocytes in vitro. We observed the formation of RFs in AxD primary cultures. The abundance of RFs was greater in AxD-transgene-homozygous compared with -hemizygous astrocytes, indicating a gene dosage effect, and this abundance increased with time in culture, indicating a developmental process effect. However, cultured AxD astrocytes did not exhibit changes in either AxCa or AxGen. We therefore conclude that RFs in astrocytes form via a cell-autonomous mechanism, whereas AxCa and AxGen are likely to occur via a non-cell-autonomous mechanism through interactions with other cells, such as neurons, microglia, and vascular cells. Although primary cultured AxD astrocytes are suitable for elucidating the mechanisms of RFs formation and for intervention studies, it should be noted that they cannot reflect the pathophysiology of non-cell-autonomous events in astrocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuropharmacology, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Chuo 409-3898, Japan.
- GLIA Center, University of Yamanashi, Chuo 409-3898, Japan.
- Division of Brain Sciences, Institute for Advanced Medical Research, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
ORCID-Profile: Eiji Shigetomi, Kenji Kobayashi, Masayoshi Tanaka, Schuichi Koizumi
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- University of Yamanashi
- JST
- JST SPRING
- JSPS Grants-in-Aid for Scientific Research (KAKENHI)
- AMED-CREST
- Takeda Science Foundation
Zitieren
APA
Kubota, Y., Shigetomi, E., Saito, K., Shinozaki, Y., Kobayashi, K., Tanaka, M., Parajuli, B., Tanaka, K. F., & Koizumi, S. (2024). Establishment and Use of Primary Cultured Astrocytes from Alexander Disease Model Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212100
Vancouver
Kubota Y, Shigetomi E, Saito K, Shinozaki Y, Kobayashi K, Tanaka M, et al. Establishment and Use of Primary Cultured Astrocytes from Alexander Disease Model Mice. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212100
BibTeX
@article{Kubota2024,
author = {Kubota, Yuto and Shigetomi, Eiji and Saito, Kozo and Shinozaki, Youichi and Kobayashi, Kenji and Tanaka, Masayoshi and Parajuli, Bijay and Tanaka, Kenji F and Koizumi, Schuichi},
title = {Establishment and Use of Primary Cultured Astrocytes from Alexander Disease Model Mice},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212100}
}
EUVIMED